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AIMS AND OBJECTIVES:  The aim of this study was to compare the MRI findings, and 
response to neoadjuvant therapy using MRI tumor regression grading in patients with 
rectal cancer below the age of 25 years with patients more than 25 years of age. 
 
MATERIALS AND METHODS: Partly retrospective and partly prospective study 
approved by the institutional review board. 27 patients below 25 years of age and 115 
older patients above 25 years of age with locally advanced rectal cancer were included in 
the study. Both the subsets of patients had MRI for initial staging and for restaging 
following neoadjuvant therapy. The various MRI features of the tumor, TNM staging, 
MRI tumor regression grade and histological features of the tumor were assessed. 
RESULTS: On bivariate analysis, the incidence of tumors with MRI T2 high signal 
intensity in patients ≤ 25 years of age was higher, 48.1 % compared to 19.3% in patients 
>25 years of age. The incidence of poor response to neoadjuvant therapy (by MRI tumor 
regression grade) was significantly more common in younger patients (66.7%) compared 
to older patients (40.9%). Factors like age less than 25 years, T2 high signal intensity, 
presence of EMVI, mucinous tumors and poorly differentiated tumors were significantly 
associated with poor response to neoadjuvant therapy. T2 high signal in MRI and 
presence of EMVI were found to be two independent predictors for poor response. 
 
